CrushSCI.com
71Average days
56Median days
20Fastest days
142Longest days
3212025 publications

Paper Review Records

All Paper Review Records

13 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

142 days

Affordability of CGRP-targeted therapies and physician support for reimbursement in Southeast Asia and East Asia: a cross-country analysis from the SEALANT study

Authors
Wanakorn Rattanawong; Akarin Hiransuthikul; Supakorn Chansaengpetch; Prakit Anukoolwittaya; Thanakit Pongpitakmetha; Sekh Thanprasertsuk; Nijanth Manohararaj; Wan Aliaa Wan Sulaiman; Gerard Saranza; John Luis Wee; Greg Dayrit; Irma Savitri Madjid; Devi Ariani Sudibyo; Pepi Budianto; Jr-Wei Wu; Appasone Phoumindr; Chananchida Sirilertmekasakul; Surat Tanprawate; Stewart J. TepperShow moreShow less
Affiliations
1. Department of Medicine, Faculty of Medicine, King Mongkut’s Institute of Technology Ladkrabang, Bangkok, Thailand; 2. Center for Natural and Artificial Intelligence (CNAI), Faculty of Medicine, King Mongkut’s Institute of Technology Ladkrabang, Bangkok, Thailand; 3. Comprehensive Headache and Orofacial Pain (CHOP) Service and Research Group, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand; 4. Department of Preventive and Social Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand; 5. Division of Neurology, Department of Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand; 6. Department of Pharmacology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand; 7. Department of Physiology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand; 8. Department of Neurology, National Neuroscience Institute, Singapore, Singapore; 9. Department of Neurology, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, Serdang, Malaysia; 10. Movement Disorders Service, Chong Hua Hospital & Vicente Sotto Memorial Medical Center, Cebu, Philippines; 11. Section of Neurology, Department of Internal Medicine, Chong Hua Hospital, Cebu, Philippines; 12. Department of Neurosciences, University of the Philippines- Philippine General Hospital, Manila, Philippines; 13. Departments of Anatomy & Internal Medicine, Cebu Institute of Medicine, Cebu, Philippines; 14. Department of Internal Medicine, Chong Hua Hospital, Cebu, Philippines; 15. Department of Neurosciences, St. Luke’s Medical Center College of Medicine -WHQM, Quezon City, Philippines; 16. Department of Neurology, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia; 17. Department of Neurology, Faculty of Medicine, Universitas Airlangga, Surabaya, Indonesia; 18. Department of Neurology, Faculty of Medicine, Universitas Sebelas Maret, Jawa Tengah, Indonesia; 19. National Yang Ming Chiao Tung University, Taipei, Taiwan; 20. Department of Internal Medicine, Faculty of Medicine, University of Health Sciences, Vientiane Capital, Lao People’s Democratic Republic; 21. Division of Neurology, Department of Internal Medicine, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand; 22. The Northern Neuroscience Center, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand; 23. The New England Institute for Neurology and Headache, Stamford, USAShow moreShow less
Official full-text evidence DOI Publisher page
42 days

Migraine prevention with eptinezumab in real life – a retrospective Swiss cohort study

Authors
Vera A. Fankhauser; Franz Riederer; Reto M. Agosti; Bettina Anders; Philipp Balcerak; Lívia Granata; Jeremia Held; Christian P. Kamm; Antonella Palla; Athina Papadopoulou; Alexandre Pfister; Heiko Pohl; Jean‐Benoît Rossel; Philippe Ryvlin; Laura Maria Schmid; Kean Schönholzer; Adrian Scutelnic; Nedelina Slavova; Anamaria Ungureanu; Susanne Wegener; Chiara Zecca; Andreas R. Gantenbein; Christoph Josef SchankinShow moreShow less
Affiliations
1. University of Bern; 2. University Hospital of Bern; 3. University of Zurich; 4. GastroZentrum Hirslanden Zürich; 5. Bellevue Medical Group, Zurich, Switzerland; 6. Kantonsspital St. Gallen; 7. Schmerzzentrum Granata, Zurich, Switzerland; 8. Luzerner Kantonsspital; 9. University Hospital Zurich; 10. University of Basel; 11. University Hospital of Basel; 12. Centre Hospitalier Universitaire Vaudois; 13. Hôpital Orthopédique de la Suisse Romande; 14. Università della Svizzera italiana; 15. ZURZACH Care AGShow moreShow less
Official full-text evidence DOI Publisher page
99 days

Pre-pregnancy migraine diagnosis, medication use, and spontaneous abortion: a prospective cohort study

Authors
Holly M. Crowe; Amelia K. Wesselink; Lauren A. Wise; Susan S. Jick; Kenneth J. Rothman; Ellen M. Mikkelsen; Henrik T. Sørensen; Elizabeth E. HatchShow moreShow less
Affiliations
1. Harvard T.H. Chan School of Public Health, Department of Epidemiology, Boston, USA; 2. Boston University School of Public Health, Department of Epidemiology, Boston, USA; 3. Aarhus University, Department of Clinical Epidemiology, Aarhus N, DenmarkShow moreShow less
Source PDF DOI Publisher page
20 days

Longitudinal changes in functional connectivity and pain-induced brain activations in patients with migraine: a functional MRI study pre- and post- treatment with Erenumab

Authors
Todd J. Schwedt; Simona Nikolova; Gina Dumkrieger; Jing Li; Teresa Wu; Catherine D. ChongShow moreShow less
Affiliations
1. Department of Neurology, Mayo Clinic, Phoenix, USA; 2. School of Industrial and Systems Engineering, Georgia Tech, Atlanta, USA; 3. School of Computing, Informatics, Decision Systems Engineering, Arizona State University, Tempe, USAShow moreShow less
Source PDF DOI Publisher page
142 days

Migraine epidemiology and comorbidities in Southern Israel: a clinical database study in a universal health coverage setting

Authors
Ido Peles; Mohnnad Asla; Mariya Abayev; Michal Gordon; Victor Novack; Rinat Ribalov; Tamar Lengil; Ron Maor; Mayera Elizur; Gal IferganeShow moreShow less
Affiliations
1. Clinical Research Center, Soroka University Medical Center and the Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel; 2. Department of Neurology, Brain Medicine Division, Soroka University Medical Center and the Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel; 3. Internal Medicine Division, Soroka University Medical Center and the Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel; 4. Teva Pharmaceuticals Industries Ltd, Tel Aviv, IsraelShow moreShow less
Source PDF DOI Publisher page
56 days

The premonitory phase of migraine is due to hypothalamic dysfunction: revisiting the evidence

Authors
Cedric Gollion; Roberto De Icco; David W. Dodick; Hakan AshinaShow moreShow less
Affiliations
1. Danish Headache Center, Department of Neurology, Rigshospitalet, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark; 2. Department of Neurology, University Hospital of Toulouse, Toulouse, France; 3. Department of Brain and Behavioral Science, University of Pavia, Pavia, Italy; 4. Headache Science & Neurorehabilitation Center, IRCCS Mondino Foundation, Pavia, Italy; 5. Department of Neurology, Mayo Clinic, Scottsdale, USA; 6. Department of Clinical Medicine, Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark; 7. Department of Neurorehabilitation / Traumatic Brain Injury, Rigshospitalet, Copenhagen, Denmark; 8. Department of Anesthesia, Critical Care and Pain Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, USAShow moreShow less
Source PDF DOI Publisher page

FAQ

How long does JOURNAL OF HEADACHE AND PAIN take to review a manuscript?

As of 2026-11-19, CrushSCI has 13 complete review records for JOURNAL OF HEADACHE AND PAIN. The fastest paper went from submission to acceptance in 20 days (Longitudinal changes in functional connectivity and pain-induced brain activations in patients with migraine: a functional MRI study pre- and post- treatment with Erenumab, received 2022-09-17, accepted 2022-10-07); the slowest took 142 days. The average is 71 days and the median is 56 days.

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

We will reply within 30 minutes.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review59.6 days

Median65 days

Contact CrushSCI

Contact CrushSCI

Leave your email address to discuss academic polishing, structural refinement, or one-to-one guidance.

We will reply within 30 minutes.

Selected service: Academic Consulting Service

Leave your email address

Or email us directly at leader@crushsci.com

Enter your email address so we can reply. Your details will remain private.